Join Annette Bowyer as She Explores Heparin-Induced Thrombocytopenia!
Sysmex Europe Haemostasis shared on LinkedIn:
”We are delighted to launch Season 2 of our haemostasis webinar series “Haemostasis and Beyond. Meet the Expert”!
Our first session will focus on an important topic:
Heparin-induced thrombocytopenia (HIT) – a severe complication in patients treated with heparins, including unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH). HIT can result in serious thromboembolic events, often associated with considerable morbidity and mortality.
Join Annette Bowyer as she explores:
- What HIT is and how it develops
- Current approaches to diagnosis and management
- The essential role of the HISCL HIT IgG assay kit in supporting patient care
Save the date: 16.10.2025, 11:00 CEST
Link.
Do not miss the opening session of Season 2 – expand your knowledge, meet the experts, and stay at the forefront of haemostasis diagnostics.”
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Jun 10, 2026, 04:58Edward Lee Carter: What If Better Stroke Prevention Didn’t Require More Bleeding?
-
Jun 10, 2026, 04:50Antoine Francis: Plasma as the Internet of the Human Body
-
Jun 10, 2026, 04:45Judith Catella: New Evidence on Distal Deep Vein Thrombosis from the RIETE Registry
-
Jun 10, 2026, 04:20Ravindra Prasad Thokala: When T Cells Heal and Harm in the Same Transplant Unit
-
Jun 10, 2026, 04:15Jukka Partanen: How Blood Donation Selection Shapes the Human Genome Landscape
-
Jun 10, 2026, 04:02Heghine Khachatryan: What Should We Test From a Hematologic Perspective in Young Cryptogenic Stroke?
-
Jun 9, 2026, 17:55Can We Prevent Postpartum Blood Clots without Putting Most Women on Heparin? – RPTH Journal
-
Jun 9, 2026, 17:54Lucky Oseghale Oloboh: Health Is Power, Health Is Personal, and Health Is Our First Responsibility in Life’s Journey on Mother Earth
-
Jun 9, 2026, 17:53Ajay Samkaria: How ABO Subgroups Directly Impact Transfusion Safety